Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis

Keyphrases

• Alanine Aminotransferase 25%
• Anti-inflammatory Cytokines 50%
• Antibiotics 100%
• Antimicrobial 25%
• Antimicrobial Activity 50%
• Antimicrobial Peptides 50%
• Aspartate Aminotransferase 25%
• B Lymphocytes 25%
• Bacterial Clearance 25%
• Bacterial Growth 25%
• Biochemical Parameters 25%
• Bone Marrow 25%
• Cecal Ligation 75%
• Cecal Puncture 75%
• Clinical Syndromes 25%
• Clinical Treatment 25%
• Combination Therapy 100%
• Endometrial Stem Cells 25%
• Expression Level 25%
• Flow Cytometry 25%
• Growth Assay 25%
• Hepcidin 25%
• High-level Expression 25%
• Histological Parameters 25%
• Inflammatory Response 25%
• Liver Enzymes 25%
• Lymphocyte Subsets 25%
• Mesenchymal Stem Cells 100%
• Morbidity Rate 25%
• Mortality Rate 25%
• Mouse Model 50%
• Multi-target 25%
• Organ Damage 25%
• Paracrine 25%
• Peritoneal Fluid 25%
• Polymicrobial 25%
• Proliferation Rate 25%
• Protective Effect 25%
• Quantitative PCR 25%
• Sepsis 100%
• Sepsis Model 25%
• Sepsis Treatment 25%
• Severe Inflammation 25%
• Severe Sepsis 25%
• Significant Loss 25%
• Specific Stresses 25%
• Stem Cell-derived 25%
• Stress Conditions 25%
• Survival Rate 50%
• Synergy with Antibiotics 25%
• T Cells 25%
• Therapeutic Effect 50%
• Treatment Efficacy 25%
• Treatment Morbidity 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Alanine Aminotransferase 20%
• Anti-Inflammatory Drug 40%
• Antibiotics 100%
• Antiinfective Agent 20%
• Antimicrobial Agent 60%
• Aspartate Aminotransferase 20%
• Bacterial Clearance 20%
• Cecal Ligation and Puncture-Induced Sepsis 20%
• Combination Therapy 100%
• Cytokine 40%
• Flow Cytometry 20%
• Hepcidin 20%
• Infection 20%
• Inflammation 40%
• Liver Enzyme 20%
• Morbidity 20%
• Mortality Rate 20%
• Mouse Model 40%
• Organ Injury 20%
• Polypeptide Antibiotic Agent 20%
• Sepsis 100%
• Survival Rate 40%
• Syndrome 20%
• Table Salt 20%
• Therapeutic Effect 40%

Immunology and Microbiology

• Antimicrobial Activity 33%
• Antimicrobial Agent 100%
• Antimicrobial Peptides 66%
• B Cell 33%
• Bacterial Clearance 33%
• Bacterial Growth 33%
• Inflammation Response 33%
• Inflammatory Cytokine 66%
• Lymphocyte Subpopulation 33%
• Mesenchymal Stem Cell 100%
• Morbidity 33%
• Mortality Rate 33%
• Mouse Model 66%
• Peritoneal Fluid 33%
• Quantitative Reverse Transcription Polymerase Chain Reaction 33%
• Survival Rate 66%
• Systemic Inflammation 33%